Does Orange Juice Hesperidin Cardiometabolic Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Orange Juice Hesperidin Cardiometabolic Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - However, MOJ intake increased the production of SCFAs, especially propionic and isobutyric acids, and significantly improved cardiometabolic biomarkers such as blood pressure and plasma VCAM-1 levels in the overweight women. [Corrêa TAF (2023); evidence level 4] - Furthermore, MOJ reduced fasting glucose and insulin levels and HOMA-IR values, thereby enhancing insulin sensitivity in the insulin-resistant overweight women. [Corrêa TAF (2023); evidence level 4] - In conclusion, our study demonstrated that changes in specific OTUs of the gut microbiota in response to MOJ intake were associated with significant improvements in some cardiometabolic biomarkers and SCFA levels in overweight women with insulin resistance. [Corrêa TAF (2023); evidence level 4] - Blood orange juice is an important source of flavanones and anthocyanins, mainly hesperidin, narirutin, and cyanidin-3- O -glucoside. [Corrêa TAF (2023); evidence level 4] - The intake of hesperidin-rich sources, mostly found in orange juice, can decrease cardiometabolic risk, potentially linked to the gut microbial phase-II hesperetin derivatives. [Ávila-Gálvez MÁ (2021); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.